Gene Expression Atlas home | about the project | faq | feedback | blog | das | api | help
ARL11
REST API REST API
Homo sapiens
ARL11 is differentially expressed in 96 experiments: 34 organism parts: bone marrow, cerebellum, ... (32 more);, 35 disease states: normal, control, ... (33 more);, 39 cell types 36 cell lines 10 compound treatments and 34 other conditions.
Synonyms FLJ33930, ARLTS1
Orthologs ARL11 (Bos taurus)   Arl11 (Rattus norvegicus)   Arl11 (Mus musculus)   arl11 (Danio rerio)   F1N8V9_CHICK (Gallus gallus)   arl11 (Xenopus laevis)   (Compare orthologs)
Gene Ontology Term protein binding, cytoplasm, intracellular, intracellular protein transport, GTP binding, small GTPase mediated signal transduction, nucleus, nucleotide binding
InterPro Term Gtr1_RagA, MIRO-like, SRP_receptor_beta_su, Small_GTPase, Small_GTP-bd_dom, Small_GTPase_SAR1, Small_GTPase_ARF, Small_GTPase_ARF/SAR
UniProt Accession Q969Q4
Gene-Disease Assocation LEUKEMIA, CHRONIC LYMPHOCYTIC; CLL
Search EB-eye ENSG00000152213
Show more properties
Experimental Factors
Organism part

studied in E-AFMX-5, E-GEOD-803, E-GEOD-6573, E-GEOD-18105, E-MTAB-69, ... (8 experiments)

3
1
Number of published studies where the gene is over/under expressed compared to the gene's overall mean expression level in the study.

anatomogram

Cell line

studied in E-GEOD-5823, E-GEOD-12662, E-GEOD-22152, E-GEOD-20089, E-GEOD-19639, ... (10 experiments)

Factor Value U/D Experiments
NA18499
1
E-GEOD-19480
ZR75-1
1
E-GEOD-19639
NB4
1
E-GEOD-12662
NA19171
1
E-GEOD-19480
MDA-361
1
E-GEOD-19639
NA19108
1
E-GEOD-19480
30 more value(s).


Cell type

studied in E-GEOD-18811, E-AFMX-5, E-GEOD-22373, E-GEOD-20033, E-GEOD-18147, ... (19 experiments)

Factor Value U/D Experiments
adult native RPE from 78 y.o. donor
1
E-GEOD-18811
fetal RPE
1
E-GEOD-18811
B-cell
1
1
E-GEOD-10820
iPS cells from episomal vectors (Defined Factor sub-clone)
1
E-GEOD-20033
testis - leydig cell
1
E-AFMX-5
mesendoderm/endoderm progenitor cell
1
E-MEXP-930
33 more value(s).


Disease state

studied in E-GEOD-6872, E-GEOD-15960, E-GEOD-22148, E-GEOD-9692, E-GEOD-13987, ... (28 experiments)

Factor Value U/D Experiments
astrocytoma
1
E-GEOD-4290
teratozoospermia
1
E-GEOD-6872
Kaposi's sarcoma
1
1
E-MEXP-561
monoclonal gammopathy of uncertain significance
1
E-MTAB-372
extranodal NK/T-cell lymphoma
1
E-TABM-702
NDV
1
E-GEOD-18791
29 more value(s).


Compound treatment

studied in E-GEOD-2706, E-GEOD-15205, E-GEOD-7216, E-TABM-868

Factor Value U/D Experiments
lipopolysaccharide and R848
1
E-GEOD-2706
TNF
1
1
E-GEOD-15205
interleukin-26 (Homo sapiens)
1
E-GEOD-7216
lipopolysaccharide
1
E-TABM-868
none
1
E-TABM-868
interleukin-24 (Homo sapiens)
1
1
E-GEOD-7216
4 more value(s).


Agent

studied in E-GEOD-19519

Factor Value U/D Experiments
thapsigargin
1
1
E-GEOD-19519
DMSO
1
1
E-GEOD-19519
tunicamycin
1
E-GEOD-19519


BioSourceProvider
studied in E-GEOD-19519, E-GEOD-19480

Clinical history
studied in E-GEOD-19743, E-GEOD-7967, E-GEOD-21374, E-GEOD-21589, E-GEOD-16363 ... (5 experiments)

Clinical info
studied in E-GEOD-19743, E-GEOD-19348, E-GEOD-21589, E-GEOD-16363

coriell cell line repository identifier
studied in E-GEOD-19519

Developmental stage
studied in E-GEOD-19743, E-GEOD-20033

dfs time (months)
studied in E-GEOD-21653

Disease staging
studied in E-GEOD-19743, E-GEOD-22541, E-GEOD-22148

Environmental stress
studied in E-GEOD-1643

family id
studied in E-GEOD-19519

Genetic modification
studied in E-GEOD-8023

Genotype
studied in E-TABM-1029, E-GEOD-17476, E-TABM-868, E-GEOD-17347

Growth condition
studied in E-GEOD-20504, E-MEXP-2146

Histology
studied in E-GEOD-21653, E-TABM-276

Individual
studied in E-MTAB-197, E-TABM-325, E-MEXP-2069, E-GEOD-19330, E-TABM-666, ... (15 experiments)

Infection
studied in E-GEOD-12108, E-MEXP-561

Injury
studied in E-GEOD-19743

Karyotype
studied in E-GEOD-7214

Ki67 ihc
studied in E-GEOD-21653

Material type
studied in E-GEOD-9171

Metastasis
studied in E-GEOD-18105

Organism status
studied in E-GEOD-19188

P53 ihc
studied in E-GEOD-21653

Phenotype
studied in E-GEOD-19703

Protocol type
studied in E-GEOD-19246

pt
studied in E-GEOD-21653

Sample preparation
studied in E-GEOD-16728

sampleID
studied in E-GEOD-24283

Sampling time point
studied in E-GEOD-16797, E-GEOD-19743, E-GEOD-21374

Stimulation
studied in E-GEOD-20114

Survival time
studied in E-GEOD-19188

Transfection
studied in E-GEOD-14680

Treatment
studied in E-GEOD-16837, E-GEOD-19246

Tumor grading
studied in E-GEOD-22541

Processing time: 0.394 secs.
 
Gene Expression Atlas 2.0.11.1- 12/23/11 3:09:34 PM